Hence, tailoring GATA3-mediated treatment and management plans for PD specifically and neurodegenerative disease generally becomes plausible as it seems beneficial for patients to manage their symptoms and improve their outcomes. The gene discussed is GATA3; the disease is Parkinson disease.